Startup funding activity continues to show strong investor interest in AI, fintech, space technology, biotech, and autonomous software development. Recent large funding rounds highlight where capital is flowing and which sectors are attracting significant growth-stage investment.
Based on data curated from the Intellizence Startup Funding Dataset, here are the five top startup funding deals announced during the week ending May 10th, 2026.
💸 Funding Highlights
| Company | Sector | Funding Amount | Funding Round |
|---|---|---|---|
| Kalshi | Technology | $1B | Series F |
| Sierra AI | Technology | $950M | Growth Funding |
| Astranis | Technology | $450M | Venture Series Unknown |
| Anagram Therapeutics | Biotechnology | $250M | Venture Series Unknown |
| Blitzy | Technology | $200M | Growth Funding |
Funding Deals of the Week
Kalshi Raises $1 Billion Series F at a $22 Billion Valuation
Kalshi— $1 Billion
Industry: Technology
Round: Series F
Kalshi, a prediction market platform, raised $1 billion in a Series F round, valuing the company at $22 billion. The round was led by Coatue, with participation from Sequoia Capital, Andreessen Horowitz and Morgan Stanley. Kalshi plans to use the capital to expand adoption among hedge funds, asset managers, proprietary trading firms and insurance companies. The company is also focused on building out block trading capabilities, risk products and broker integrations for institutional users.
Why This Deal Matters
Rising investor interest in prediction market as a financial infrastructure category.Prediction markets are moving beyond retail speculation and into broader use cases around risk management, event-driven trading and financial decision-making.
Sierra AI— $950 Million
Industry: Technology
Round: Growth Funding
Sierra AI has raised $950 Million at a valuation of over $15 billion. The round was led by Tiger Global and GV, valuing the company at over $15 billion. The company said it now has more than $1 billion to invest in becoming the global standard for companies that want to transform customer experiences with AI.
Why it matters
Reflects continued investor confidence in enterprise AI platforms, especially those focused on customer experience, AI agents and automation. Shows that large AI funding rounds are increasingly going toward companies building practical business applications rather than only foundational AI models.
Astranis— $450 Million
Industry: Technology
Round: Series E
Astranis raised $450 million in new capital, including a $300 million Series E equity round, bringing its total capital raised to more than $1.2 billion. The funding will help Astranis scale production of spacecraft designed for geostationary orbit and other high orbits. The Series E was led by Snowpoint and Franklin Templeton, with participation from Andreessen Horowitz, BlackRock, Baillie Gifford, Fidelity, BAM Elevate, Nimble Partners and others.
Astranis plans to use the new capital to accelerate production for commercial customers and support upcoming U.S. government programs.
Why it matters
Highlights investor interest for space infrastructure companies serving both commercial satellite demand and government defense-related programs. Smaller, dedicated high-orbit spacecraft positions it within the growing market for secure connectivity and specialized satellite capacity.
Anagram Therapeutics — $250 Million
Industry: Biotechnology
Round: Growth
Anagram Therapeutics, the clinical-stage biopharmaceutical company developing treatments for exocrine pancreatic insufficiency, received a $250 million investment from Blackstone Life Sciences. The investment will help fund the development, approval and launch of ANG003, Anagram’s orally delivered recombinant enzyme replacement therapy for people with exocrine pancreatic insufficiency due to cystic fibrosis.
Why it matters
Shows continued investment in specialty biotech companies targeting high-burden diseases. The company is developing a therapy that could reduce treatment burden for patients who currently rely on large numbers of pills each day.
Blitzy — $200 Million
Industry: Technology
Round: Growth Funding
Blitzy, an autonomous software development platform, raised $200 million in growth funding at a $1.4 billion valuation. The round was led by Northzone, with participation from PSG, Battery Ventures, Jump Capital, Morgan Creek Digital, Defiant, Flybridge, Link Ventures, NFX, Picus Capital and Venture Guides. Blitzy is building an AI-powered platform designed to autonomously complete large-scale enterprise software development work. The company says its platform can understand large enterprise codebases and execute complex development projects that traditionally take months.
Why it matters
Reflects growing demand for AI tools that go beyond developer assistance and move toward autonomous software execution. For enterprises with legacy systems, modernization backlogs and large codebases, platforms like Blitzy could become strategic productivity infrastructure.
Key Takeaways
These funding rounds show five major trends in startup investment:
- AI remains a dominant funding theme.
- Prediction markets are attracting institutional capital.
- Space infrastructure is gaining momentum.
- Biotech funding remains active for high-need clinical areas.
Growth-stage investors are backing companies with clear market expansion opportunities, especially where technology can transform large existing industries.
How Intellizence Helps You Track These Signals
Intellizence delivers curated, structured funding, M&A, expansion, and deep tech signals across industries. With the Intellizence Startup Funding Dataset, you can:
- Track mega rounds in AI & deep tech
- Monitor change in valuation
- Identify emerging AI infrastructure startups
- Spot capital rotation trends early
- Build investor and GTM intelligence workflows
If you want to turn these signals into strategic decisions, structured intelligence matters. Explore how Intellizence helps you track what moves markets—before the market reacts.
Frequently Asked Questions (FAQ)
What is startup funding data?
Startup funding data tracks private company financing events, including funding amount, round type, investors, valuation, company sector, location, and how the company plans to use the funds.
How can Intellizence help track startup funding rounds?
Intellizence provides structured startup funding data by monitoring funding announcements, investor participation, deal size, company details, valuation signals and related business context. This helps teams identify high-growth companies and market opportunities faster.
Who uses Intellizence funding data?
Intellizence funding data is useful for sales teams, marketing teams, revenue teams, private equity firms, venture capital teams, corporate development teams, market intelligence teams and competitive intelligence teams.
How does funding data help sales teams?
Funding data helps sales teams identify companies with fresh capital, new budgets and potential buying intent. A recently funded company may be hiring, expanding, investing in technology or preparing for rapid growth.
Who uses Intellizence Funding data?
- Venture Capital & Private Equity firms
- Corporate strategy and M&A teams
- Market intelligence and research teams
- Sales and GTM teams tracking high-growth accounts
How can I access the Funding Dataset?
You can access the Funding Dataset through the Intellizence web platform, API, or email alerts. Subscribers can filter by industry, geography, investor, funding round, or date for customized insights.
What is the benefit of using Intellizence instead of manually tracking funding news?
Manual tracking is time-consuming and incomplete. Intellizence converts funding announcements into structured, decision-ready data so teams can search, filter, analyze and act on funding signals faster.
Identify Emerging Opportunities & Risks